Chairman, Department of Dermatology
Joint Appointments
Molecular & Cellular Biophysics
Pharmacology & Therapeutics
The Lawrence P. and Joan Castellani Family Chair in Dermatology
Roswell Park Cancer Institute

Professor and Chairman, Department of Dermatology
School of Medicine and Biomedical Sciences
State University of New York at Buffalo

Dr. Allan R. Oseroff joined the staff of Roswell Park Cancer Institute (RPCI) in 1990, as Chairman of the Department of Dermatology. He earned his doctoral degree in Applied Physics from Harvard University, Cambridge, MA, in 1971, and his medical degree at Yale University Medical School, New Haven, CT, in 1977. He completed residency training in Medicine and Dermatology at the University of Chicago in 1980, and fellowship training in Immunology, Oncology and Dermatology at Stanford Medical Center, Palo Alto, CA, in 1982.

Dr. Oseroff is licensed by New York State and is board-certified in Internal Medicine and Dermatology. He holds joint appointments in the departments of Molecular & Cellular Biophysics and Pharmacology & Therapeutics at RPCI, and is Professor and Chair of Dermatology at the University at Buffalo School of Medicine and Biomedical Sciences.

Dr. Oseroff’s research interests focus on photomedicine; mechanisms of photodynamic therapy; new photosensitizers; molecular responses; effects of ALA-PDT on T lymphocytes and antigen presenting cells; electroporation; and imaging.

Dr. Oseroff is a member of many professional organizations, and is the recipient of over 20 research grants from federal funding agencies and foundations. Currently, he serves on the Non-Melanoma Skin Cancer Treatment Guidelines Panel, National Comprehensive Cancer Network, and on a number of committees at RPCI and the University at Buffalo.

Dr. Oseroff has authored or co-authored more than 200 journal publications, book chapters and abstracts. He is a member of the Editorial Board of the journal Lasers in Surgery and Medicine, and is a Scientific Journal Referee for 16 journals, including Applied Optics, Blood, Nature, Science, and the Journal of the National Cancer Institute.